# US 2021/0330202 A1 · Optical Imaging from Light Coherence

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330202 A1
- Document ID: US20210330202A1
- Status: Published application
- Kind: A1
- Application number: 16/904,572
- Filed: 2020-06-18
- Published: 2021-10-28
- Earliest claimed: 2020-04-27
- Assignees: Open Water Internet Inc.
- Applicants: Open Water Internet Inc.
- Inventors: Soren Konecky
- Web page: https://patentgrep.com/patent/US20210330202A1

## CPC

- A61B 5/0261: {using optical means, e.g. infrared light}
- A61B 5/0066: {Optical coherence imaging}
- A61B 5/4064: {Evaluating the brain (for intracranial pressure A61B5/031; for cerebral blood gases A61B5/14553; using EEG A61B5/369)}
- A61B 2576/026: for the brain
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Coherent light (e.g., laser light) is emitted into a tissue sample through an optical fiber. The tissue sample diffuses the coherent light. Different blood flow quantities generate different coherent light interference patterns. An image of a coherent light interference pattern is captured with an image sensor coupled to an optical fiber. The speckle contrast of the image quantifies coherent light interference pattern. The speckle contrast is determined and is mapped to blood flow quantities using one or more data models. A quantity of blood flow is identified in a tissue sample at least partially based on the speckle contrast value of the captured image.

## Claims

### Claim 1

An imaging system comprising:
a laser configured to emit laser light;
a source optical fiber coupled to the laser and configured to deliver the laser light into a tissue sample;
a detector optical fiber configured to receive diffuse laser light from portions of the laser light that exits the tissue sample;
an image sensor coupled to the detector optical fiber and configured to capture an image of the diffuse laser light exiting the tissue sample; and
processing logic configured to:
receive the image from the image sensor;
determine a coherence value of the diffuse laser light in the image; and
determine blood characteristics for the tissue sample at least partially based on the coherence value.

### Claim 2 (depends on 1)

The imaging system of claim 1 further comprising:
wherein the detector optical fiber is a multi-mode fiber.

### Claim 3 (depends on 1)

The imaging system of claim 1, wherein the laser light is a near-infrared laser light, and wherein the image sensor includes a filter to block light outside of a linewidth of the laser light.

### Claim 4 (depends on 1)

The imaging system of claim 1 further comprising:
a second image sensor configured to capture a second image of a second diffuse laser light exiting the tissue sample, wherein the image sensor is disposed at a first exit location of the tissue sample and the second image sensor is disposed at a second exit location of the tissue sample, wherein the processing logic is configured to receive the second image from the second image sensor, wherein the image and the second image are captured concurrently.

### Claim 5 (depends on 1)

The imaging system of claim 1, wherein the coherence value of the diffuse laser light in the image is determined as a speckle contrast value, which is determined as a standard deviation of pixel values of the image divided by a mean of the pixel values of the image.

### Claim 6 (depends on 1)

The imaging system of claim 1, wherein the image sensor is configured to capture reference beam laser light with the diffuse laser light,
wherein the processing logic is further configured to determine the coherence value of the diffuse laser light in the image by determining a contrast value between fringe patterns in the image.

### Claim 7 (depends on 1)

The imaging system of claim 1, wherein the processing logic is further configured to generate a composite image from multiple captures of the coherence value, wherein the composite image represents blood flow in the tissue sample, wherein the coherence value increases as blood flow decreases.

### Claim 8

An imaging method comprising:
emitting coherent light into a tissue sample;
capturing an image of an exit signal of the coherent light exiting the tissue sample;
determining a coherence value of the image; and
incorporating the coherence value into a composite image of the tissue sample.

### Claim 9 (depends on 8)

The imaging method of claim 8, wherein the coherent light is laser light having a wavelength in a range of 600-900 nm.

### Claim 10 (depends on 8)

The imaging method of claim 8, wherein capturing the image includes using an exposure time of in a range of 1 μs and 30 μs.

### Claim 11 (depends on 8)

The imaging method of claim 8, wherein at least a portion of the exit signal previously propagated deeper than two centimeters deep into the tissue sample.

### Claim 12 (depends on 8)

The imaging method of claim 8, wherein determining the coherence value includes determining a speckle contrast value for the image, wherein the speckle contrast value is a standard deviation of pixel values in the image divided by an average intensity of the pixel values in the image.

### Claim 13 (depends on 8)

The imaging method of claim 8, wherein the composite image includes a two-dimensional or three-dimensional image of a body part with one or more coherence values represented on the image of the body part.

### Claim 14 (depends on 8)

The imaging method of claim 8 further comprising:
emitting a reference beam of coherent light,
wherein capturing the image includes capturing the reference beam with the exit signal in the image,
wherein determining the coherence value for the image includes determining a contrast value between fringe patterns in the image.

### Claim 15

An imaging method comprising:
providing coherent light in a tissue sample through one or more first optical fibers;
capturing an image of coherent light interference patterns using one or more second optical fibers and an image sensor; and
determining blood characteristics at least partially based on the coherent light interference patterns.

### Claim 16 (depends on 15)

The imaging method of claim 15 further comprising:
generating a composite image of the tissue sample based on the blood characteristics.

### Claim 17 (depends on 15)

The imaging method of claim 15, wherein the blood characteristics include a volume of blood flowing through a portion of the tissue sample.

### Claim 18 (depends on 15)

The imaging method of claim 15, wherein providing the coherent light includes providing a pulse of coherent light having a duration of 10 μs to 100 μs.

### Claim 19 (depends on 15)

The imaging method of claim 15, wherein capturing the image includes limiting an exposure time of the image sensor to a window of approximately 10 μs.

### Claim 20 (depends on 15)

The imaging method of claim 15, wherein determining the blood characteristics includes determining a speckle contrast value for pixels of the image.
